This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants. The first patients are being screened to see if…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….
Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
University of Oxford and BRC: Oxford Health supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of…
Academia Meets Industry – Grand Challenges and New Horizons 16th September 2024, Mathematical Institute, Oxford The New Therapeutic Approaches in Translational Mental Health conference will bring together industry, academic and…
New research from Oxford’s Department of Education has revealed the current picture of mental health and diversity support in schools in the Midlands. The research compiled feedback from 48 primary…
MQ Mental Health Research would like to hear form you if you have taken part in a mental health clinical trial that involved testing new medicines. They are putting together…
Staff from Oxford Health’s Clinical Research Facility (CRF) spent two engaging days at the UK CRF Network conference in Leicester from 4-5 July 2024. Although the event took place during…
BRC: Oxford Health Researchers from the Universities of Birmingham, Oxford, Reading and Surrey met in Guildford on 1 July to tour the sleep facilities and discuss sleep technologies. At the…
A study partnership involving University of Oxford researchers from the BRC: Oxford Health’s Brain Technologies Theme, Great Ormond Street Hospital, University College London and King’s College Hospital were recently involved…
Professor Rachel Upthegrove, who joins the University of Oxfords Department of Psychiatry and our BRC as Director Designate in August, has been made an MBE in the King’s Birthday Honours…
Launched 21 May 2024: Funding for new sites to join the Mood Disorder Research Clinic Network This is open to all Trusts across the 4 Nations. Please contact Julie Bieles…
Our BRC Better Sleep (BS) Theme aims to create a UK collaborating network that integrates research infrastructure and clinical services to deliver innovation in mental, cognitive and brain health research…
The Patient and Public Involvement (PPI) team from the BRC: Oxford Health Preventing Multiple Morbidities (PMM) Theme, recently collaborated on a project with Care Coordinators from the Oxford Health NHS…
